Our research uniquely addresses this gap by elucidating the interplay between gut leakage, cytokine spillover (e.g., IL-17), microbial translocation, and immune cell trafficking (via α4β7 and CCR9) in driving pulmonary inflammation (Fig 6). The gene discussed is IL17A; the disease is inflammation.